Skip to content
10-K/A

Annual Report

RenovoRx, Inc. RNXT

0001193125-26-227256

← back to feed
Filed
May 15, 2026 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 23, 2026 45.05M sh